Study questions anti-cancer mechanisms of drug tested in clinical trials
"However, our findings unveil a potential role for AMPK as a tumor growth supporter, not a suppressor, in the type of cancer that we study. This is why clinicians…
My Personal Biomedical Research Feed – Ralph Turchiano, CEO Alchepharma
"However, our findings unveil a potential role for AMPK as a tumor growth supporter, not a suppressor, in the type of cancer that we study. This is why clinicians…
Contact: Will Sansom sansom@uthscsa.edu 210-567-2579 University of Texas Health Science Center at San Antonio UT Health Science Center at San Antonio, other centers reach same result: 28-38 percent longer life…
Public release date: 8-Jul-2009 - other centers reach same result: 28-38 percent longer life results were the same in Texas, Michigan and Maine. - “I did not think that it…
You must be logged in to post a comment.